AimTo compare prevalence rates of non-alcoholic fatty liver disease (NAFLD) between Hispanics of Mexican origin and Hispanics of Dominican and Puerto Rican origin.MethodsWe evaluated prevalence rates of NAFLD between the two largest sub-populations of Hispanics in the United States; Hispanics of Mexican origin and Hispanics of Caribbean origin (Dominican and Puerto Rican), in the multi-ethnic study of atherosclerosis (MESA) cohort. MESA is a large, population based, multi-center cohort study comprised of 6814 healthy Caucasian, African-American, Hispanic, and Asian men and women aged 45-84. We utilized the baseline serum, anthropometric and radiographic measurements obtained between 2000 and 2002. NAFLD was measured via computed tomography ...
AimTo compare the prevalence of chronic liver disease (CLD) risk factors in a representative sample ...
Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease is one of...
Background/Objective: Nonalcoholic fatty liver disease affects 30% of the world adult population. It...
Background & aimsNonalcoholic fatty liver disease (NAFLD) was shown to disproportionally affect ...
Non-alcoholic fatty liver disease (NAFLD) is spreading worldwide, with a racial/ethnic disparity. We...
Objective—To characterize the prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) by race in a n...
Hepatic steatosis (HS) is a growing problem in adults worldwide, with racial/ethnic disparity in the...
The incidence of nonalcoholic fatty liver disease (NAFLD) is highest among Mexican-origin (MO) adult...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease which includes simple steatosis, ...
NAFLD is characterized by accumulation of fat in the liver that can lead to health complications. Pr...
Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide with a co...
Krisztina B Szanto,1,2 Jiawei Li,2,3 Paul Cordero,2 Jude A Oben2,4 1Faculty of Life Sciences and Med...
Background: Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome predicted to be the nex...
AimTo compare the prevalence of chronic liver disease (CLD) risk factors in a representative sample ...
Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease is one of...
Background/Objective: Nonalcoholic fatty liver disease affects 30% of the world adult population. It...
Background & aimsNonalcoholic fatty liver disease (NAFLD) was shown to disproportionally affect ...
Non-alcoholic fatty liver disease (NAFLD) is spreading worldwide, with a racial/ethnic disparity. We...
Objective—To characterize the prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) by race in a n...
Hepatic steatosis (HS) is a growing problem in adults worldwide, with racial/ethnic disparity in the...
The incidence of nonalcoholic fatty liver disease (NAFLD) is highest among Mexican-origin (MO) adult...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
Nonalcoholic fatty liver disease (NAFLD) is a progressive condition that includes steatosis (NAFL) a...
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease which includes simple steatosis, ...
NAFLD is characterized by accumulation of fat in the liver that can lead to health complications. Pr...
Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide with a co...
Krisztina B Szanto,1,2 Jiawei Li,2,3 Paul Cordero,2 Jude A Oben2,4 1Faculty of Life Sciences and Med...
Background: Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome predicted to be the nex...
AimTo compare the prevalence of chronic liver disease (CLD) risk factors in a representative sample ...
Nonalcoholic fatty liver disease (NAFLD) is an alarming public health problem. The disease is one of...
Background/Objective: Nonalcoholic fatty liver disease affects 30% of the world adult population. It...